San Diego BioProcess Forum

November 14, 2012 - San Diego BioProcess Forum Meeting

Wednesday, November 14th, 2012 at 5:30pm - 7:30pm

Location: Sheppard Mullin LLP

This event is in the past.

San Diego BioProcess Forum 
Cordially Invites You to our Last 2012 Meeting.

Featuring a presentation by:

Chad Green, Ph.D.
Director, Device Engineering and Manufacturing, Viacyte

“Developing a Encapsulated Stem Cell-Derived Therapy for Diabetes” 

ViaCyte is a preclinical therapeutic company focused on diabetes with a goal of providing insulin independence on a long-term basis, while reducing or eliminating hypoglycemic, microvasculature, and weight-related cardiovascular complications. Our therapy is based on the differentiation of stem cells into pancreatic beta cell precursors followed by subcutaneous implantation in an encapsulation device. This device, known as the Encaptra® Drug Delivery System, is retrievable, non-biodegradable, biocompatible and protects against allorejection such that the implanted pancreatic progenitor cells survive and differentiate into functioning islet cells capable of producing insulin in response to glucose. Using current data, this presentation will review the Encaptra® Drug Delivery System and ViaCyte’s recent progress towards the development of a stem cell-derived combination product to treat diabetes.


Please RSVP to reserve your space.
Membership and Event admission are FREE.
Go to "Upcoming Events" page on
 to RSVP.

We may share participants' information with our sponsors. By registering for this event, you agree to these terms.

Meeting Date/Time
Wednesday November 14, 2012
5:30PM – 7:30PM
Presentation at 6:30PM

Sheppard Mullin LLP
12275 El Camino Real, Suite 200
San Diego CA 92130

Food, beverages, and venue provided by our sponsors:


Meetings - Club/Group Meeting

Export to your calendar

San Diego BioProcess Forum

Powered by GroupSpaces · Terms · Privacy Policy · Cookie Use · Create Your Own Group